{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T20:44:09Z","timestamp":1794861849835,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006058","name":"St. Baldrick\u2019s Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009741","name":"AABB | National Blood Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009741","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0417"],"award-info":[{"award-number":["W81XWH-20-1-0417"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005440","name":"U.S. Department of Health & Human Services | NIH | Center for Scientific Review","doi-asserted-by":"publisher","award":["RO1CA226983"],"award-info":[{"award-number":["RO1CA226983"]}],"id":[{"id":"10.13039\/100005440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biomed Eng"],"DOI":"10.1038\/s41551-021-00842-6","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T16:15:39Z","timestamp":1645460139000},"page":"118-128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":303,"title":["Rapid manufacturing of non-activated potent CAR T cells"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2415-3576","authenticated-orcid":false,"given":"Saba","family":"Ghassemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Durgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selene","family":"Nunez-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Leferovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilia","family":"Pinzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9041-0828","authenticated-orcid":false,"given":"Katherine D.","family":"Cummins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4279-5943","authenticated-orcid":false,"given":"Gabriela","family":"Plesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito Adrian","family":"Cantu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantan","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic D.","family":"Bushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saar I.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Una","family":"O\u2019Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5645-4544","authenticated-orcid":false,"given":"Roddy S.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1580-9844","authenticated-orcid":false,"given":"Michael C.","family":"Milone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"key":"842_CR1","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1182\/blood-2018-01-785840","volume":"131","author":"AI Salter","year":"2018","unstructured":"Salter, A. I., Pont, M. J. & Riddell, S. R. Chimeric antigen receptor-modified T cells: CD19 and the road beyond. Blood 131, 2621\u20132629 (2018).","journal-title":"Blood"},{"key":"842_CR2","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1200\/JCO.2018.77.8084","volume":"36","author":"JN Brudno","year":"2018","unstructured":"Brudno, J. N. et al. T cells genetically modified to express an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of poor-prognosis relapsed multiple myeloma. J. Clin. Oncol. 36, 2267\u20132280 (2018).","journal-title":"J. Clin. Oncol."},{"key":"842_CR3","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1172\/JCI126397","volume":"129","author":"AD Cohen","year":"2019","unstructured":"Cohen, A. D. et al. B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma. J. Clin. Investig. 129, 2210\u20132221 (2019).","journal-title":"J. Clin. Investig."},{"key":"842_CR4","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1158\/2159-8290.CD-17-1417","volume":"8","author":"SP D\u2019Angelo","year":"2018","unstructured":"D\u2019Angelo, S. P. et al. Antitumor activity associated with prolonged persistence of adoptively transferred NY-ESO-1 (c259)T cells in synovial sarcoma. Cancer Discov. 8, 944\u2013957 (2018).","journal-title":"Cancer Discov."},{"key":"842_CR5","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1056\/NEJMoa1817226","volume":"380","author":"N Raje","year":"2019","unstructured":"Raje, N. et al. Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma. N. Engl. J. Med. 380, 1726\u20131737 (2019).","journal-title":"N. Engl. J. Med."},{"key":"842_CR6","doi-asserted-by":"publisher","first-page":"95ra73","DOI":"10.1126\/scitranslmed.3002842","volume":"3","author":"M Kalos","year":"2011","unstructured":"Kalos, M. et al. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci. Transl. Med. 3, 95ra73 (2011).","journal-title":"Sci. Transl. Med."},{"key":"842_CR7","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1158\/2326-6066.CIR-17-0405","volume":"6","author":"S Ghassemi","year":"2018","unstructured":"Ghassemi, S. et al. Reducing ex vivo culture improves the antileukemic activity of chimeric antigen receptor (CAR) T cells. Cancer Immunol. Res. 6, 1100\u20131109 (2018).","journal-title":"Cancer Immunol. Res."},{"key":"842_CR8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1172\/JCI32103","volume":"118","author":"C Berger","year":"2008","unstructured":"Berger, C. et al. Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. J. Clin. Investig. 118, 294\u2013305 (2008).","journal-title":"J. Clin. Investig."},{"key":"842_CR9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.immuni.2014.05.018","volume":"41","author":"P Graef","year":"2014","unstructured":"Graef, P. et al. Serial transfer of single-cell-derived immunocompetence reveals stemness of CD8+ central memory T cells. Immunity 41, 116\u2013126 (2014).","journal-title":"Immunity"},{"key":"842_CR10","doi-asserted-by":"publisher","first-page":"17469","DOI":"10.1073\/pnas.0907448106","volume":"106","author":"CS Hinrichs","year":"2009","unstructured":"Hinrichs, C. S. et al. Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity. Proc. Natl Acad. Sci. USA 106, 17469\u201317474 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"842_CR11","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1182\/blood-2010-05-286286","volume":"117","author":"CS Hinrichs","year":"2011","unstructured":"Hinrichs, C. S. et al. Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy. Blood 117, 808\u2013814 (2011).","journal-title":"Blood"},{"key":"842_CR12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1172\/JCI81217","volume":"126","author":"CA Klebanoff","year":"2016","unstructured":"Klebanoff, C. A. et al. Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy. J. Clin. Invest. 126, 318\u2013334 (2016).","journal-title":"J. Clin. Invest."},{"key":"842_CR13","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1158\/0008-5472.CAN-14-2277","volume":"75","author":"JG Crompton","year":"2015","unstructured":"Crompton, J. G. et al. Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics. Cancer Res. 75, 296\u2013305 (2015).","journal-title":"Cancer Res."},{"key":"842_CR14","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1182\/blood-2014-05-578583","volume":"124","author":"AB van der Waart","year":"2014","unstructured":"van der Waart, A. B. et al. Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy. Blood 124, 3490\u20133500 (2014).","journal-title":"Blood"},{"key":"842_CR15","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nm.1982","volume":"15","author":"L Gattinoni","year":"2009","unstructured":"Gattinoni, L. et al. Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nat. Med. 15, 808\u2013813 (2009).","journal-title":"Nat. Med."},{"key":"842_CR16","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/nm.2446","volume":"17","author":"L Gattinoni","year":"2011","unstructured":"Gattinoni, L. et al. A human memory T cell subset with stem cell-like properties. Nat. Med. 17, 1290\u20131297 (2011).","journal-title":"Nat. Med."},{"key":"842_CR17","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.4049\/jimmunol.1101585","volume":"187","author":"S Muralidharan","year":"2011","unstructured":"Muralidharan, S. et al. Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytes. J. Immunol. 187, 5221\u20135232 (2011).","journal-title":"J. Immunol."},{"key":"842_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1126\/science.272.5259.263","volume":"272","author":"L Naldini","year":"1996","unstructured":"Naldini, L. et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263\u2013267 (1996).","journal-title":"Science"},{"key":"842_CR19","doi-asserted-by":"publisher","first-page":"13938","DOI":"10.1128\/JVI.01745-07","volume":"81","author":"G Plesa","year":"2007","unstructured":"Plesa, G. et al. Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cells. J. Virol. 81, 13938\u201313942 (2007).","journal-title":"J. Virol."},{"key":"842_CR20","doi-asserted-by":"publisher","first-page":"14179","DOI":"10.1128\/JVI.79.22.14179-14188.2005","volume":"79","author":"WJ Swiggard","year":"2005","unstructured":"Swiggard, W. J. et al. Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli. J. Virol. 79, 14179\u201314188 (2005).","journal-title":"J. Virol."},{"key":"842_CR21","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1182\/blood-2013-11-540641","volume":"123","author":"F Amirache","year":"2014","unstructured":"Amirache, F. et al. Mystery solved: VSV-G-LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor. Blood 123, 1422\u20131424 (2014).","journal-title":"Blood"},{"key":"842_CR22","doi-asserted-by":"publisher","first-page":"7306","DOI":"10.1073\/pnas.1214441110","volume":"110","author":"D Finkelshtein","year":"2013","unstructured":"Finkelshtein, D., Werman, A., Novick, D., Barak, S. & Rubinstein, M. LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus. Proc. Natl Acad. Sci. USA 110, 7306\u20137311 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"842_CR23","doi-asserted-by":"publisher","first-page":"8153","DOI":"10.1128\/JVI.00220-09","volume":"83","author":"LM Agosto","year":"2009","unstructured":"Agosto, L. M. et al. The CXCR4-tropic human immunodeficiency virus envelope promotes more-efficient gene delivery to resting CD4+ T cells than the vesicular stomatitis virus glycoprotein G envelope. J. Virol. 83, 8153\u20138162 (2009).","journal-title":"J. Virol."},{"key":"842_CR24","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1128\/JVI.01851-10","volume":"85","author":"MJ Pace","year":"2011","unstructured":"Pace, M. J., Agosto, L. & O\u2019Doherty, U. R5 HIV env and vesicular stomatitis virus G protein cooperate to mediate fusion to naive CD4+ T cells. J. Virol. 85, 644\u2013648 (2011).","journal-title":"J. Virol."},{"key":"842_CR25","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1084\/jem.189.11.1735","volume":"189","author":"D Unutmaz","year":"1999","unstructured":"Unutmaz, D., KewalRamani, V. N., Marmon, S. & Littman, D. R. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J. Exp. Med. 189, 1735\u20131746 (1999).","journal-title":"J. Exp. Med."},{"key":"842_CR26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1182\/blood-2003-01-0297","volume":"102","author":"S Cavalieri","year":"2003","unstructured":"Cavalieri, S. et al. Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competence. Blood 102, 497\u2013505 (2003).","journal-title":"Blood"},{"key":"842_CR27","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1128\/JVI.01770-15","volume":"90","author":"B Trinite","year":"2016","unstructured":"Trinite, B., Chan, C. N., Lee, C. S. & Levy, D. N. HIV-1 Vpr- and reverse transcription-induced apoptosis in resting peripheral blood CD4 T cells and protection by common gamma-chain cytokines. J. Virol. 90, 904\u2013916 (2016).","journal-title":"J. Virol."},{"key":"842_CR28","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1182\/blood-2002-07-2224","volume":"101","author":"E Verhoeyen","year":"2003","unstructured":"Verhoeyen, E. et al. IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes. Blood 101, 2167\u20132174 (2003).","journal-title":"Blood"},{"key":"842_CR29","doi-asserted-by":"publisher","first-page":"6526","DOI":"10.1128\/JVI.73.8.6526-6532.1999","volume":"73","author":"YD Korin","year":"1999","unstructured":"Korin, Y. D. & Zack, J. A. Nonproductive human immunodeficiency virus type 1 infection in nucleoside-treated G0 lymphocytes. J. Virol. 73, 6526\u20136532 (1999).","journal-title":"J. Virol."},{"key":"842_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-016-0275-8","volume":"13","author":"A Rausell","year":"2016","unstructured":"Rausell, A. et al. Innate immune defects in HIV permissive cell lines. Retrovirology 13, 43 (2016).","journal-title":"Retrovirology"},{"key":"842_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-9-87","volume":"9","author":"B Descours","year":"2012","unstructured":"Descours, B. et al. SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4+ T-cells. Retrovirology 9, 87 (2012).","journal-title":"Retrovirology"},{"key":"842_CR32","doi-asserted-by":"publisher","first-page":"8518","DOI":"10.1128\/JVI.76.17.8518-8513.2002","volume":"76","author":"TC Pierson","year":"2002","unstructured":"Pierson, T. C. et al. Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection. J. Virol. 76, 8518\u20138531 (2002).","journal-title":"J. Virol."},{"key":"842_CR33","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1038\/mt.2009.83","volume":"17","author":"MC Milone","year":"2009","unstructured":"Milone, M. C. et al. Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo. Mol. Ther. 17, 1453\u20131464 (2009).","journal-title":"Mol. Ther."},{"key":"842_CR34","doi-asserted-by":"crossref","unstructured":"Burnie, J. & Guzzo, C. The incorporation of host proteins into the external HIV-1 envelope. Viruses 11, 85 (2019).","DOI":"10.3390\/v11010085"},{"key":"842_CR35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature21405","volume":"543","author":"J Eyquem","year":"2017","unstructured":"Eyquem, J. et al. Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection. Nature 543, 113\u2013117 (2017).","journal-title":"Nature"},{"key":"842_CR36","doi-asserted-by":"crossref","unstructured":"Wilen, C. B., Tilton, J. C. & Doms, R. W. HIV: cell binding and entry. Cold Spring Harb. Perspect. Med. 2, a006866 (2012).","DOI":"10.1101\/cshperspect.a006866"},{"key":"842_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1126\/science.3513311","volume":"232","author":"MS Brown","year":"1986","unstructured":"Brown, M. S. & Goldstein, J. L. A receptor-mediated pathway for cholesterol homeostasis. Science 232, 34\u201347 (1986).","journal-title":"Science"},{"key":"842_CR38","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.ymthe.2017.07.002","volume":"25","author":"R Tran","year":"2017","unstructured":"Tran, R. et al. Microfluidic transduction harnesses mass transport principles to enhance gene transfer efficiency. Mol. Ther. 25, 2372\u20132382 (2017).","journal-title":"Mol. Ther."},{"key":"842_CR39","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","volume":"371","author":"SL Maude","year":"2014","unstructured":"Maude, S. L. et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N. Engl. J. Med. 371, 1507\u20131517 (2014).","journal-title":"N. Engl. J. Med."},{"key":"842_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.omtm.2016.11.003","volume":"4","author":"CC Berry","year":"2017","unstructured":"Berry, C. C. et al. INSPIIRED: quantification and visualization tools for analyzing integration site distributions. Mol. Ther. Methods Clin. Dev. 4, 17\u201326 (2017).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"842_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.omtm.2016.11.002","volume":"4","author":"E Sherman","year":"2017","unstructured":"Sherman, E. et al. INSPIIRED: a pipeline for quantitative analysis of sites of new DNA integration in cellular genomes. Mol. Ther. Methods Clin. Dev. 4, 39\u201349 (2017).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"842_CR42","doi-asserted-by":"crossref","unstructured":"Berry, C. C. et al. Estimating abundances of retroviral insertion sites from DNA fragment length data. Bioinformatics 28, 755\u2013762 (2012).","DOI":"10.1093\/bioinformatics\/bts004"},{"key":"842_CR43","doi-asserted-by":"crossref","unstructured":"Nobles, C. L. et al. CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration. J. Clin. Invest. 130, 673\u2013685 (2019).","DOI":"10.1172\/JCI130144"},{"key":"842_CR44","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0092-8674(02)00864-4","volume":"110","author":"AR Schroder","year":"2002","unstructured":"Schroder, A. R. et al. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110, 521\u2013529 (2002).","journal-title":"Cell"},{"key":"842_CR45","doi-asserted-by":"publisher","first-page":"E234","DOI":"10.1371\/journal.pbio.0020234","volume":"2","author":"RS Mitchell","year":"2004","unstructured":"Mitchell, R. S. et al. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2, E234 (2004).","journal-title":"PLoS Biol."},{"key":"842_CR46","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1101\/gr.6286907","volume":"17","author":"GP Wang","year":"2007","unstructured":"Wang, G. P., Ciuffi, A., Leipzig, J., Berry, C. C. & Bushman, F. D. HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res. 17, 1186\u20131194 (2007).","journal-title":"Genome Res."},{"key":"842_CR47","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1097\/QAD.0b013e32832caf28","volume":"23","author":"T Brady","year":"2009","unstructured":"Brady, T. et al. HIV integration site distributions in resting and activated CD4+ T cells infected in culture. AIDS 23, 1461\u20131471 (2009).","journal-title":"AIDS"},{"key":"842_CR48","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1182\/blood-2005-03-1082","volume":"106","author":"WN Haining","year":"2005","unstructured":"Haining, W. N. et al. Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia. Blood 106, 1749\u20131754 (2005).","journal-title":"Blood"},{"key":"842_CR49","first-page":"99","volume":"37","author":"B Halliwell","year":"2014","unstructured":"Halliwell, B. Cell culture, oxidative stress, and antioxidants: avoiding pitfalls. Biomed. J. 37, 99\u2013105 (2014).","journal-title":"Biomed. J."},{"key":"842_CR50","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.4049\/jimmunol.179.7.4910","volume":"179","author":"H Zhang","year":"2007","unstructured":"Zhang, H. et al. 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy. J. Immunol. 179, 4910\u20134918 (2007).","journal-title":"J. Immunol."},{"key":"842_CR51","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1158\/1078-0432.CCR-11-0503","volume":"17","author":"CA Klebanoff","year":"2011","unstructured":"Klebanoff, C. A. et al. Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice. Clin. Cancer Res. 17, 5343\u20135352 (2011).","journal-title":"Clin. Cancer Res."},{"key":"842_CR52","doi-asserted-by":"crossref","unstructured":"Klebanoff, C. A. et al. Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy. JCI Insight 2, e95103 (2017).","DOI":"10.1172\/jci.insight.95103"},{"key":"842_CR53","doi-asserted-by":"publisher","first-page":"10074","DOI":"10.1128\/JVI.74.21.10074-10080.2000","volume":"74","author":"U O\u2019Doherty","year":"2000","unstructured":"O\u2019Doherty, U., Swiggard, W. J. & Malim, M. H. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J. Virol. 74, 10074\u201310080 (2000).","journal-title":"J. Virol."},{"key":"842_CR54","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1038\/nm.2964","volume":"18","author":"HM Baldauf","year":"2012","unstructured":"Baldauf, H. M. et al. SAMHD1 restricts HIV-1 infection in resting CD4+ T cells. Nat. Med. 18, 1682\u20131687 (2012).","journal-title":"Nat. Med."},{"key":"842_CR55","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.1021\/acs.biochem.8b01038","volume":"57","author":"CH Mauney","year":"2018","unstructured":"Mauney, C. H., Perrino, F. W. & Hollis, T. Identification of inhibitors of the dNTP triphosphohydrolase SAMHD1 using a novel and direct high-throughput assay. Biochemistry 57, 6624\u20136636 (2018).","journal-title":"Biochemistry"},{"key":"842_CR56","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/mt.2009.282","volume":"18","author":"GD Trobridge","year":"2010","unstructured":"Trobridge, G. D. et al. Cocal-pseudotyped lentiviral vectors resist inactivation by human serum and efficiently transduce primate hematopoietic repopulating cells. Mol. Ther. 18, 725\u2013733 (2010).","journal-title":"Mol. Ther."},{"key":"842_CR57","doi-asserted-by":"publisher","first-page":"9571","DOI":"10.1073\/pnas.0503726102","volume":"102","author":"CA Klebanoff","year":"2005","unstructured":"Klebanoff, C. A. et al. Central memory self\/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc. Natl Acad. Sci. USA 102, 9571\u20139576 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"842_CR58","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/eji.1830250227","volume":"25","author":"KE Pollok","year":"1995","unstructured":"Pollok, K. E., Kim, S. H. & Kwon, B. S. Regulation of 4-1BB expression by cell\u2013cell interactions and the cytokines, interleukin-2 and interleukin-4. Eur. J. Immunol. 25, 488\u2013494 (1995).","journal-title":"Eur. J. Immunol."},{"key":"842_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7483","volume":"6","author":"M Lelek","year":"2015","unstructured":"Lelek, M. et al. Chromatin organization at the nuclear pore favours HIV replication. Nat. Commun. 6, 6483 (2015).","journal-title":"Nat. Commun."},{"key":"842_CR60","doi-asserted-by":"publisher","first-page":"9702","DOI":"10.1128\/JVI.01669-15","volume":"89","author":"RW Wong","year":"2015","unstructured":"Wong, R. W., Mamede, J. I. & Hope, T. J. Impact of nucleoporin-mediated chromatin localization and nuclear architecture on HIV integration site selection. J. Virol. 89, 9702\u20139705 (2015).","journal-title":"J. Virol."},{"key":"842_CR61","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1126\/science.356.6343.1112","volume":"356","author":"J Couzin-Frankel","year":"2017","unstructured":"Couzin-Frankel, J. Supply of promising T cell therapy is strained. Science 356, 1112\u20131113 (2017).","journal-title":"Science"},{"key":"842_CR62","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.4049\/jimmunol.1102757","volume":"189","author":"RS O\u2019Connor","year":"2012","unstructured":"O\u2019Connor, R. S. et al. Substrate rigidity regulates human T cell activation and proliferation. J. Immunol. 189, 1330\u20131339 (2012).","journal-title":"J. Immunol."},{"key":"842_CR63","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1373\/clinchem.2013.219378","volume":"60","author":"W De Spiegelaere","year":"2014","unstructured":"De Spiegelaere, W. et al. Quantification of integrated HIV DNA by repetitive-sampling Alu-HIV PCR on the basis of poisson statistics. Clin. Chem. 60, 886\u2013895 (2014).","journal-title":"Clin. Chem."},{"key":"842_CR64","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ymeth.2009.01.002","volume":"47","author":"MK Liszewski","year":"2009","unstructured":"Liszewski, M. K., Yu, J. J. & O\u2019Doherty, U. Detecting HIV-1 integration by repetitive-sampling Alu-gag PCR. Methods 47, 254\u2013260 (2009).","journal-title":"Methods"},{"key":"842_CR65","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/leu.2015.52","volume":"29","author":"SS Kenderian","year":"2015","unstructured":"Kenderian, S. S. et al. CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia. Leukemia 29, 1637\u20131647 (2015).","journal-title":"Leukemia"}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-021-00842-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-021-00842-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-021-00842-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T17:11:55Z","timestamp":1733937115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-021-00842-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":65,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["842"],"URL":"https:\/\/doi.org\/10.1038\/s41551-021-00842-6","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,21]]},"assertion":[{"value":"10 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.C.M. is an inventor on patent applications related to CAR technology (US patents 9,481,728 and 9,499,629 B2) and has received licencing royalties from the Novartis corporation. S.G. and M.C.M. are inventors on a patent application related to methods of manufacturing non-activated CAR T cells (provisional patent PCT\/US2020\/027734). The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}